Share buyback 2020
ISIN DE0005470405 / WKN 547040
The Board of Management of LANXESS AG resolved on March 10, 2020, in line with the authorization granted by the Annual Stockholders’ Meeting on May 23, 2019, to buy own shares at a total volume of up to €500 million divided into two tranches of €250 million each, on the stock exchange. The first tranche of the share repurchase began on March 12, 2020. In light of the coronavirus pandemic, the Board of Management decided on April 6, 2020, to suspend the share repurchase program until further notice with immediate effect. LANXESS AG repurchased 1,101,549 own shares by this date. This equates to 1.26% of the company’s outstanding capital stock. The total repurchase volume amounted to €36,698,254.49, equating to an average price of around €33.32 per repurchased share.
Following the announced acquisition of IFF’s microbial control business, LANXESS stated that the suspended share buy-back program will not be continued.
The repurchased shares were cancelled on 22 September 2021.